Logo-Avivia-W-transparant

Bridging the Gap From API to Pharmaceutical Formulations

Avivia has four integrated platforms:

Avivia has four complementary pharmaceutical R&D speciality service platforms:

Avivia for all

 

Big Pharma, speciality pharma, small entrepreneurial drug development firms, generic drug companies, universities, excipient manufacturers, law firms and even venture capital firms… our customer base is very broad and diverse.  Although most of our activities are focused on wet-lab product development, we also provide hands-on support services in fields such as IP protection and development, investor’s due diligence, upscaling support, deformulation analysis, life cycle management strategy development, etc.

We have learned that serving many players with very different interests makes us stronger!

Be it the protection or creation of new formulation patents for originator products or the evasion of established formulation patents for generic drug development, we are constantly seeking new IP opportunities to maximize product value. Combined, our team are inventors on more than 30 granted patents on diverse drug products.

Patents are in our DNA!

IP creation, protection and evasion

IP creation, protection and evasion

Be it the protection or creation of new formulation patents for originator products or the evasion of established formulation patents for generic drug development, we are constantly seeking new IP opportunities to maximize product value. Combined, our team are inventors on more than 30 granted patents on diverse drug products. Patents are in our DNA!

Avivia in numbers

Number of unique molecules worked on by Avivia team members
0
Number of patents filed by Avivia team members
0
Average number of client projects we complete every year
0
Lee Ayres Managing director Avivia BV

“So, this is Avivia in a nutshell. I hope we have been able to trigger your interest so far! In the ‘Services’ and ‘Lab Capabilities’ sections of our website you can find the different services we offer to pharmaceutical, generics and drug development companies.  If you are interested to learn more about Avivia, don’t hesitate to contact us and we would be happy to help you accelerating your development programs!”

Lee Ayres, Managing Director Avivia BV